Advertisement

Zika Debate In Congress04:47
Download

Play
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAD), speaks with Dr. Sylvain Aldighieri, Zika Incident Manager for the Pan American Health Organization (PAHO), during a media briefing concerning the Zika virus, at the Pan American Health Organization headquarters, May 3, 2016, in Washington, DC. (Drew Angerer/Getty Images)
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAD), speaks with Dr. Sylvain Aldighieri, Zika Incident Manager for the Pan American Health Organization (PAHO), during a media briefing concerning the Zika virus, at the Pan American Health Organization headquarters, May 3, 2016, in Washington, DC. (Drew Angerer/Getty Images)
This article is more than 4 years old.

After several months of back and forth between the White House and Congress, the Senate will vote today on Zika funding. A $1.1 billion bipartisan compromise is likely to get Senate approval. The Obama Administration had asked for more money. What does a delay in funding mean for research? And where is the US on developing a vaccine? Here and Now's Robin Young speak with Alison Kodjak, health policy correspondent for NPR.

Guest

This segment aired on May 17, 2016.

Advertisement

Advertisement